Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Lynch

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Nature Methods|November 14, 2006
SCALEs: multiscale analysis of library enrichmentMichael D Lynch, Tanya Warnecke, Ryan T Gill
Hardwarex|May 2, 2022
BioSamplr: An open source, low cost automated sampling system for bioreactorsJohn P Efromson, Shuai Li, Michael D Lynch
Metabolic Engineering|July 25, 2009
Genes restoring redox balance in fermentation-deficient E. coli NZN111Amarjeet Singh, Michael D Lynch, Ryan T Gill
The CRISPR Journal|December 21, 2020
CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting RatesEirik A Moreb, Mitchell Hutmacher, Michael D Lynch
Biochemical Engineering Journal|March 21, 2022
Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidateJohn S Decker, Romel Menacho-Melgar, Michael D Lynch
Biotechniques|August 25, 2021
Optimization of phosphate-limited autoinduction broth for two-stage heterologous protein expression in <i>Escherichia coli</i>Romel Menacho-Melgar, Jennifer N Hennigan, Michael D Lynch
Biorxiv : the Preprint Server for Biology|January 12, 2022
Integrated Autolysis, DNA Hydrolysis and Precipitation Enables an Improved Bioprocess for Q-Griffithsin, a Broad-Spectrum Antiviral and Clinical-Stage anti-COVID-19 CandidateJohn S Decker, Romel Menacho-Melgar, Michael D Lynch
Biotechnology and Bioengineering|February 12, 2010
Broad-host-range vectors for protein expression across gram negative hostsJamie E Prior, Michael D Lynch, Ryan T Gill
Frontiers in Bioengineering and Biotechnology|September 25, 2020
Low-Cost, Large-Scale Production of the Anti-viral Lectin GriffithsinJohn S Decker, Romel Menacho-Melgar, Michael D Lynch
Biotechnology Journal|April 23, 2024
Phase separation methods for protein purification: A meta-analysis of purification performance and cost-effectivenessJohn S Decker, Utsuki Yano, Romel Menacho Melgar, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Nature Methods|November 14, 2006
SCALEs: multiscale analysis of library enrichmentMichael D Lynch, Tanya Warnecke, Ryan T Gill
Hardwarex|May 2, 2022
BioSamplr: An open source, low cost automated sampling system for bioreactorsJohn P Efromson, Shuai Li, Michael D Lynch
Metabolic Engineering|July 25, 2009
Genes restoring redox balance in fermentation-deficient E. coli NZN111Amarjeet Singh, Michael D Lynch, Ryan T Gill
The CRISPR Journal|December 21, 2020
CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting RatesEirik A Moreb, Mitchell Hutmacher, Michael D Lynch
Biochemical Engineering Journal|March 21, 2022
Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidateJohn S Decker, Romel Menacho-Melgar, Michael D Lynch
Biotechniques|August 25, 2021
Optimization of phosphate-limited autoinduction broth for two-stage heterologous protein expression in <i>Escherichia coli</i>Romel Menacho-Melgar, Jennifer N Hennigan, Michael D Lynch
Biorxiv : the Preprint Server for Biology|January 12, 2022
Integrated Autolysis, DNA Hydrolysis and Precipitation Enables an Improved Bioprocess for Q-Griffithsin, a Broad-Spectrum Antiviral and Clinical-Stage anti-COVID-19 CandidateJohn S Decker, Romel Menacho-Melgar, Michael D Lynch
Biotechnology and Bioengineering|February 12, 2010
Broad-host-range vectors for protein expression across gram negative hostsJamie E Prior, Michael D Lynch, Ryan T Gill
Frontiers in Bioengineering and Biotechnology|September 25, 2020
Low-Cost, Large-Scale Production of the Anti-viral Lectin GriffithsinJohn S Decker, Romel Menacho-Melgar, Michael D Lynch
Biotechnology Journal|April 23, 2024
Phase separation methods for protein purification: A meta-analysis of purification performance and cost-effectivenessJohn S Decker, Utsuki Yano, Romel Menacho Melgar, et al.
Pageof 4